Metronomic Cyclophosphamide and Methotrexate Chemotherapy in Patients with Heavily Pretreated Metastatic Breast Cancer: A Useful Palliative Regimen?

被引：0
|
作者：
Rush, H. [1 ]
Shanmugasundaram, M. [1 ]
Sandri, I. [1 ]
Karapanagiotou, E. [1 ]
Mansi, J. [1 ]
机构：
[1] Guys & St Thomass NHS Fdn Trust, London, England
来源：
CLINICAL ONCOLOGY | 2018年 / 30卷 / 06期
关键词：
D O I：
10.1016/j.clon.2018.02.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E45 / E46
页数：5
相关论文
共 50 条
  • [21] Prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients
    Montagna, E.
    Pagan, E.
    Cancello, G.
    Sangalli, C.
    Bagnardi, V.
    Munzone, E.
    Iorfida, M.
    Mazza, M.
    Dellapasqua, S.
    Bianco, N.
    Veronesi, P.
    Colleoni, M. A.
    ANNALS OF ONCOLOGY, 2020, 31 : S72 - S72
  • [22] Metronomic oral cyclophosphamide (CTX) in patients (pts) with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC)
    Fea, E.
    Vanella, P.
    Miraglio, E.
    Cauchi, C.
    Colantonio, I.
    Denaro, N.
    Di Costanzo, G.
    Garrone, O.
    Granetto, C.
    Occelli, M.
    Ricci, V.
    Vandone, A. M.
    Merlano, M. C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] The Palliative CMF is a Reasonable Salvage Treatment Option in Heavily Pretreated Patients With Metastatic Breast Cancer
    Park, J.
    Lim, Y.
    Lee, K. H.
    Han, S. W.
    Oh, D. Y.
    Im, S. A.
    Kim, T. Y.
    Bang, Y. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S346 - S346
  • [24] Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer
    Sun Young Rha
    Yong Hwa Moon
    Hei Chul Jeung
    Yong Tae Kim
    Joo Hyuk Sohn
    Woo Ick Yang
    Chang Ok Suh
    Gwi Eon Kim
    Jae Kyung Roh
    Hyun Cheol Chung
    Breast Cancer Research and Treatment, 2005, 90 : 215 - 221
  • [25] Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer
    Rha, SU
    Moon, YH
    Jeung, HC
    Kim, YT
    Sohn, JH
    Yang, WI
    Suh, CO
    Kim, GE
    Roh, JK
    Chung, HC
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 90 (03) : 215 - 221
  • [26] Phase I study of sunitinib in combination with metronomic dosing of cyclophosphamide and methotrexate in patients with metastatic breast cancer
    Lyandres, L.
    Melisko, M.
    Moasser, M.
    Goga, A.
    Park, J. W.
    Rugo, H. S.
    CANCER RESEARCH, 2009, 69 (02) : 286S - 286S
  • [27] Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer
    Orlando, Laura
    Cardillo, Anna
    Ghisini, Raffaella
    Rocca, Andrea
    Balduzzi, Alessandra
    Torrisi, Rosalba
    Peruzzotti, Giulia
    Goldhirsch, Aron
    Pietri, Elisabetta
    Colleoni, Marco
    ANNALS OF ONCOLOGY, 2006, 17 : 76 - 76
  • [28] Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer
    Orlando, Laura
    Cardillo, Anna
    Ghisini, Raffaella
    Rocca, Andrea
    Balduzzi, Alessandra
    Torrisi, Rosalba
    Peruzzotti, Giulia
    Goldhirsch, Aron
    Pietri, Elisabetta
    Colleoni, Marco
    BMC CANCER, 2006, 6 (1)
  • [29] CLINICAL IMPACT OF METRONOMIC ORAL COMBINATION CHEMOTHERAPY WITH CAPECITABINE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER
    Fujihara, Miwa
    Ohtani, Shoichiro
    Ito, Mistuya
    Kajiwara, Yukiko
    Yoshimura, Yuri
    BREAST, 2015, 24 : S40 - S40
  • [30] Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer
    Laura Orlando
    Anna Cardillo
    Raffaella Ghisini
    Andrea Rocca
    Alessandra Balduzzi
    Rosalba Torrisi
    Giulia Peruzzotti
    Aron Goldhirsch
    Elisabetta Pietri
    Marco Colleoni
    BMC Cancer, 6
12345